GaryACroghanMDPhD

Oncology • Rochester, MN

Genitourinary Oncology, Melanoma, Thoracic Cancer

Associate Professor, Oncology, Mayo Medical School.

Join to view full profile

Dr. Croghan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Croghan's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1994 - 1997
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1991 - 1994
SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)Internship, Internal Medicine, 1990 - 1991
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1990
Roswell Park Cancer InstitutePost-Doctoral Fellowship, 1982 - 1986

Certifications & Licensure

MN State Medical License 1991 - 2025

Awards, Honors, & Recognition

Mayo Teachers' Hall of Fame Inductee Mayo Cinic, Rochester, Minnesota, 2008
Summa Cum Laude with Thesis Honors SUNY at Buffalo Medical School, 1990
PhD General Experimental Pathology Roswell Park Cancer Institute, 1983

Clinical Trials

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma Start of enrollment: 2005 Oct 01
Completed
Phase 2
Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2006 Oct 01
Completed
Phase 2

Publications & Presentations

PubMed

34 citations
Second primary tumors following tobacco dependence treatments among head and neck cancer patients.
Yolanda I. Garces, Darrell R. Schroeder, Liza M. Nirelli, Gary A. Croghan, Ivana T. Croghan
American Journal of Clinical Oncology. 2007-10-01
39 citations
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Alex A. Adjei, Gary A. Croghan, Charles Erlichman, Randolph S. Marks, Joel M. Reid
Clinical Cancer Research. 2003-07-01
68 citations
Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
Lawrence D. Papsidero, Gary A. Croghan, Mary Jane O'Connell, Luis A. Valenzuela, Takuma Nemoto
Cancer Research. 1983-04-01